Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

Athira Pharma, Inc. (ATHA) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 Gengos Andrew (See Below) has filed a Form 4 on Athira Pharma, Inc.
Txns: Bought 422 shares @ $3.3576, valued at $1.4k
Bought 2,859 shares @ $3.4, valued at $9.7k
Bought 11,719 shares @ $3.4395, valued at $40.3k
06/06/2023 4 Gengos Andrew (See Below) has filed a Form 4 on Athira Pharma, Inc.
Txns: Bought 10,012 shares @ $2.75, valued at $27.5k
Bought 6,582 shares @ $2.8598, valued at $18.8k
Bought 3,418 shares @ $2.945, valued at $10.1k
Bought 15,000 shares @ $3, valued at $45k
Bought 10,000 shares @ $2.9997, valued at $30k
Bought 10,000 shares @ $2.9999, valued at $30k
Bought 10,000 shares @ $3.0154, valued at $30.2k
06/06/2023 4 MOEBIUS HANS (Chief Medical Officer) has filed a Form 4 on Athira Pharma, Inc.
Txns: Granted 7,764 shares @ $2.41, valued at $18.7k
Exercised 7,882 options to buy @ $1.35, valued at $10.6k
03/31/2023 4 PICKERING GRANT (Director) has filed a Form 4 on Athira Pharma, Inc.
Txns: Bought 10,000 shares @ $2.33, valued at $23.3k
Bought 15,000 shares @ $2.47, valued at $37.1k
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/23/2023 4 Worthington Mark (General Counsel) has filed a Form 4 on Athira Pharma, Inc.
Txns: Granted 150,000 options to buy @ $3.37, valued at $505.5k
01/23/2023 4 MOEBIUS HANS (Chief Medical Officer) has filed a Form 4 on Athira Pharma, Inc.
Txns: Granted 200,000 options to buy @ $3.37, valued at $674k
01/23/2023 4 MILESON GLENNA (CFO) has filed a Form 4 on Athira Pharma, Inc.
Txns: Granted 150,000 options to buy @ $3.37, valued at $505.5k
01/23/2023 4 Lenington Rachel (COO) has filed a Form 4 on Athira Pharma, Inc.
Txns: Granted 200,000 options to buy @ $3.37, valued at $674k
01/23/2023 4 CHURCH KEVIN (Executive VP, Research) has filed a Form 4 on Athira Pharma, Inc.
Txns: Granted 657 shares @ $2.74, valued at $1.8k
Granted 150,000 options to buy @ $3.37, valued at $505.5k
12/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/17/2022 4 MOEBIUS HANS (Chief Medical Officer) has filed a Form 4 on Athira Pharma, Inc.
Txns: Exercised 7,881 options to buy @ $1.35, valued at $10.6k
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Lenington Rachel (COO) has filed a Form 4 on Athira Pharma, Inc.
Txns: Granted 10,000 shares @ $0
Sold 4,193 shares @ $2.69, valued at $11.3k
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 PICKERING GRANT (Director) has filed a Form 4 on Athira Pharma, Inc.
Txns: Granted 3,467 options to buy @ $8.93, valued at $31k
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Kosacz Barbara (Director) has filed a Form 4 on Athira Pharma, Inc.
Txns: Granted 13,871 options to buy @ $8.93, valued at $123.9k
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/12/2022 4 MILESON GLENNA (CFO) has filed a Form 4 on Athira Pharma, Inc.
Txns: Exercised 3,000 options to buy @ $10.64, valued at $31.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy